Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Instadeep Ltd. is currently engaged in the Biotechnology & Pharmaceuticals technology area with 1 pending office action. This activity is localized within 1 distinct art unit. The presence of 1 pending office action suggests a targeted approach to its current patent prosecution strategy. This focus indicates a strategic emphasis on a particular technical niche within the Biotechnology & Pharmaceuticals sector.
The prosecution involves 1 distinct examiner. THOMPSON, MILANA KAYE is the busiest examiner for the portfolio, handling 1 pending office action. This indicates that the company's current interactions with the patent office are limited to a single point of contact. The use of 1 distinct examiner suggests a centralized review process where all communication is directed through this official, which simplifies the management of the portfolio.
Because there is 1 pending office action and 1 distinct examiner, the portfolio's immediate progress is tied to a single examiner's desk. For practitioners, the presence of 1 pending office action in 1 distinct art unit means the prosecution path is very specific. Since THOMPSON, MILANA KAYE handles 1 pending office action, the outcome depends on this individual's interpretation of the claims.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| THOMPSON, MILANA KAYE | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17827309 | MACHINE LEARNING FOR AMINO ACID CHAIN EVALUATION | THOMPSON, MILANA KAYE | 45d overdue |
| Art Unit | Apps |
|---|---|
| 1687 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17827309 | MACHINE LEARNING FOR AMINO ACID CHAIN EVALUATION | THOMPSON, MILANA KAYE | 1687 | §101§103 | Final Rejection | 45d overdue | Pending | May 27, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial